News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the three top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse disease areas and stages of precision medicine development.
UK Biobank Develops a Multi-Modal AI Foundation Model to Advance Precision Medicine
Imperial College London Debuts its Functional Genomics Network to Facilitate Translational Research
Alamar Biosciences and Partners Advance Multi-Omics for Alzheimer’s Disease
Gnosis launches the First Non-Invasive Liquid-Based Cytology Test for Early Endometrial Cancer Detection
New UK Legislation To Deliver Personalised Care to Patients More Rapidly
Plexision Secures $765K to Transform Transplant Outcomes with AI
Biomarkers & Precision Medicine 2025: Uniting Global Innovation to Shape the Future of Precision Healthcare
The World Health Organization Calls for Stronger Infrastructure and Data Systems to Advance Precision Medicine
Google DeepMind’s AlphaGenome Seeks to Decode ‘Junk’ DNA
Pixelgen Technologies Awarded $14.7million from the European Innovation Council (EIC) Accelerator
Medical Research Council Awards £1.6 million Towards Developing Dementia Diagnostic Tool
  Empatica Introduces EmbraceMini to Advance Digital Biomarker Collection in Clinical Research
New Nanoneedle Technology Could Replace Painful Biopsies in Cancer Care
AstraZeneca and Aptar Digital Health Team Up to Facilitate Early Detection of Chronic Kidney Disease
Spatial Mapping Uncovers a Group of Genes Involved in Crohn’s Disease Complication
New Gene Therapy Delivery Device Could Create Personalised Medicines in Hospital
NHS Plans Nationwide Newborn DNA Sequencing to Assess Disease Risk